CompuGroup Medical SE & Co. KGaA
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of CompuGroup Medical SE & Co. KGaA generated cash of $179,528,000, which is more than the previous year. Cash used in financing activities reached the amount of -$80,687,000 last year. Net change in cash is therefore -$26,056,000.
Cash Flow
| 2014 | 31.94M | -57.27M | 23.11M |
|---|---|---|---|
| 2015 | 73.24M | -60.63M | -9.06M |
| 2016 | 67.61M | -49.38M | -15.7M |
| 2017 | 85.82M | -54.94M | -27.98M |
| 2018 | 136.34M | -47.48M | -93.41M |
| 2019 | 110.49M | -139.44M | 49.67M |
| 2020 | 149.93M | -457.11M | 338.07M |
| 2021 | 165.27M | -163.97M | 30.15M |
| 2022 | 145.02M | -145.41M | -16.35M |
| 2023 | 179.52M | -124.32M | -80.68M |
0MSD.L Cash Flow Statement (2014 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 90.51M | 107.34M | 75.91M | 46.35M | 25.30M | 30.36M | 27.75M | 25.05M | 21.46M | 23.45M |
Operating activities | ||||||||||
Net income | 46.87M | 74.11M | 69.03M | 73.42M | 66.15M | 92.59M | 31.68M | 44.47M | 38.62M | 24.09M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | 115.79M | 112.32M | 110.71M | 75.70M | 62.85M | 44.60M | 38.37M | 43.82M | 44.54M | 42.78M |
Stock-based compensation expense | 0 | 2.64M | 5.71M | 5.88M | 3.89M | 95K | 0 | 0 | 0 | 0 |
| Deferred income tax benefit | 0 | 2.64M | 5.71M | 5.88M | 3.89M | 95K | 0 | 0 | 0 | 0 |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 11.11M | -46.58M | -21.71M | -34.24M | -3.45M | -6.79M | 1.55M | -6.34M | -12.98M | -7.05M |
Inventories | 10.58M | -8.78M | -2.28M | 9.49M | -6.23M | -7.07M | -6.99M | 1.42M | -584K | -685K |
Accounts payable | -21.07M | 15.56M | 23.91M | 11.26M | 4.09M | -4.7M | 11.92M | 3.35M | 1.45M | 0 |
Cash generated by operating activities | 179.52M | 145.02M | 165.27M | 149.93M | 110.49M | 136.34M | 85.82M | 67.61M | 73.24M | 31.94M |
Investing activities | ||||||||||
Purchases Of Investments | 0 | -4.63M | -6.05M | -2.02M | 0 | 0 | -5.49M | -2.75M | -3.78M | 0 |
Investments In Property Plant And Equipment | -18.97M | -81.03M | -77.49M | -55.72M | -43.74M | -40.35M | -41.56M | -39.61M | -24.43M | -24.92M |
Acquisitions Net | -50.23M | -64.72M | -93.75M | -398.91M | -94.35M | -4.59M | -12.69M | -9.48M | -4.72M | -31.64M |
Cash generated by investing activities | -124.32M | -145.41M | -163.97M | -457.11M | -139.44M | -47.48M | -54.94M | -49.38M | -60.63M | -57.27M |
Financing activities | ||||||||||
Common Stock Issued | 0 | 0 | 243.93M | 337.98M | 0 | 290.25M | 0 | 0 | 0 | 0 |
Payments for dividends | -26.11M | -26.11M | -26.36M | -24.20M | -24.41M | -17.40M | -17.40M | -17.40M | -17.40M | -17.40M |
Repurchases of common stock | 0 | -9.10M | -96.09M | 472.12M | -41.06M | -24.96M | 0 | 0 | 0 | 0 |
Repayments of term debt | -50.03M | 44.58M | -91.14M | -447.43M | 134.49M | -341.26M | -10.15M | -64.83M | 8.49M | -302.44M |
Cash used in financing activities | -80.68M | -16.35M | 30.15M | 338.07M | 49.67M | -93.41M | -27.98M | -15.7M | -9.06M | 23.11M |
Net Change In Cash | -26.05M | -16.82M | 31.43M | 29.56M | 21.04M | -5.06M | 2.60M | 2.69M | 3.59M | -1.98M |
Cash at end of period | 64.46M | 90.51M | 107.34M | 75.91M | 46.35M | 25.30M | 30.36M | 27.75M | 25.05M | 21.46M |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |